XML 51 R41.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 03, 2021
Oct. 04, 2020
Oct. 03, 2021
Oct. 04, 2020
Jan. 03, 2021
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax $ 1,166,684 $ 964,025 $ 3,702,844 $ 2,428,139  
Contract with Customer, Asset and Liability [Abstract]          
Contract with Customer, Asset, Net, Current 57,800   57,800   $ 59,500
Contract with Customer, Liability, Current 209,600   209,600   $ 238,100
Contract with Customer, Liability, Revenue Recognized     (79,800)    
Unbilled Receivables Transferred To Accounts Receivables     (48,900)    
Contract with Customer, Liability, Increase (Decrease)     51,300    
Contract with Customer, Asset, Increase (Decrease)     47,200    
Transferred at Point in Time [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 928,479 812,327 2,755,160 1,976,436  
Transferred over Time [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 238,205 151,698 947,684 451,703  
Americas [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 497,484 387,339 1,648,829 978,603  
Europe [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 356,204 313,486 1,149,758 767,106  
Asia [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 312,996 263,200 904,257 682,430  
Discovery & Analytical Solutions [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 512,879 423,623 1,480,317 1,213,020  
Discovery & Analytical Solutions [Member] | Transferred at Point in Time [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 374,147 293,460 1,079,119 827,270  
Discovery & Analytical Solutions [Member] | Transferred over Time [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 138,732 130,163 401,198 385,750  
Discovery & Analytical Solutions [Member] | Americas [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 217,117 173,992 599,170 503,490  
Discovery & Analytical Solutions [Member] | Europe [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 135,940 115,281 416,974 337,435  
Discovery & Analytical Solutions [Member] | Asia [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 159,822 134,350 464,173 372,095  
Diagnostics [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 653,805 540,402 2,222,527 1,215,119  
Diagnostics [Member] | Customer Concentration Risk [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 94,800   492,800    
Diagnostics [Member] | Transferred at Point in Time [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 554,332 518,867 1,676,041 1,149,166  
Diagnostics [Member] | Transferred over Time [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 99,473 21,535 546,486 65,953  
Diagnostics [Member] | Americas [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 280,367 213,347 1,049,659 475,113  
Diagnostics [Member] | Europe [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 220,264 198,205 732,784 429,671  
Diagnostics [Member] | Asia [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 153,174 128,850 440,084 310,335  
Life Sciences [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 320,067 251,929 905,949 734,782  
Life Sciences [Member] | Discovery & Analytical Solutions [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 320,067 251,929 905,949 734,782  
Life Sciences [Member] | Diagnostics [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 0 0 0 0  
Diagnostics [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 653,805 540,402 2,222,527 1,215,119  
Diagnostics [Member] | Discovery & Analytical Solutions [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 0 0 0 0  
Diagnostics [Member] | Diagnostics [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 653,805 540,402 2,222,527 1,215,119  
Applied Markets [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 192,812 171,694 574,368 478,238  
Applied Markets [Member] | Discovery & Analytical Solutions [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax 192,812 171,694 574,368 478,238  
Applied Markets [Member] | Diagnostics [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax $ 0 $ 0 $ 0 $ 0